Regulus Therapeutics Inc.'s (NASDAQ:RGLS) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week
Ownership data and analyst forecasts provide insight into a company's potential. Regulus Therapeutics Inc. has institutions as the major shareholders with significant gains for investors. Understanding various shareholder types and analyst sentiments is crucial for assessing a company's prospects.